GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Investments And Advances

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Investments And Advances : $0.00 Mil (As of Dec. 2022)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Investments And Advances?

CERo Therapeutics Holdings's Investments And Advances for the quarter that ended in Dec. 2022 was $0.00 Mil.


CERo Therapeutics Holdings Investments And Advances Historical Data

The historical data trend for CERo Therapeutics Holdings's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Investments And Advances Chart

CERo Therapeutics Holdings Annual Data
Trend Dec21 Dec22
Investments And Advances
- -

CERo Therapeutics Holdings Semi-Annual Data
Dec21 Dec22
Investments And Advances - -

CERo Therapeutics Holdings Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines